4/16/2018 9:55 AM
Biopharmaceutical stock Alkermes Plc (NASDAQ:ALKS) is rallying this morning after the U.S. Food and Drug Administration (FDA) accepted the company's new drug application (NDA) for ALKS 5461, a treatm...
3/8/2016 2:19 PM
Analysts are weighing in on biotech Celldex Therapeutics, Inc. (NASDAQ:CLDX) , oil-and-gas stock EP Energy Corp (NYSE:EPE) , and Sam Adams parent Boston Beer Co Inc (NYSE:SAM) . Here's a quick roundup...
3/7/2016 10:08 AM
U.S. stocks are slightly lower this morning, despite rising crude oil futures. Among equities in focus are chemical giant DuPont (NYSE:DD), drugmaker Celldex Therapeutics, Inc. (NASDAQ:CLDX), and sem...
8/11/2015 4:56 PM
The Dow took a 212-point step back, following China's decision to devalue the yuan. Across all 12 options exchanges, 7.89 million calls crossed, compared to 8.50 million puts. The day's put/call vol...
7/15/2015 2:46 PM
The major market indexes are looking to extend their winning streaks, though upside momentum is relatively muted compared to the big gains of the past few days. However, one sector that's standing o...